Palatin Technologies (PTN)

PTN was delisted on the 8th of May, 2025.

• Market cap: $2.45M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.

Employees: 30